对基于DNA甲基化的乳腺瘤血管生成表观遗传调节的新见解
Sharath Mohan Bhat1, Palla Ranga Prasad1, Manjunath B Joshi1
1Department of Ageing Research, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
International review of cell and molecular biology
|September 1, 2023
概括
DNA甲基化调节乳腺瘤血管生成. 亲血管性基因的低甲基化和抗血管性基因的高甲基化影响瘤生长和患者的存活率,提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 乳腺瘤依赖血管新生生生长和转移,与异常的瘤血管阻碍治疗疗效.
- 表观遗传变化,特别是DNA甲基化,破坏了血管生成因子的平衡,导致血管生成失调.
研究的目的:
- 审查DNA甲基化在调节乳腺瘤血管生成中的作用.
- 通过DNA甲基转移酶 (DNMTs) 共同调节的内皮细胞中识别新的亲血管性基因.
- 探索DNA甲基化模式与患者存活率之间的相关性.
主要方法:
- 对DNA甲基化对血管生成的影响的文献综述.
- 对乳腺瘤中的基因表达和DNA甲基化数据的分析.
- 基因与CpG岛屿的鉴定由DNMTs.co-regulated进行.
主要成果:
- 亲血管性基因促进剂被低甲基化,而抗血管性基因促进剂被高甲基化.
- 这些甲基化模式与基因表达水平相关.
- 新型亲血管性基因显示,促进体DNA甲基化强度与患者存活率有显著的关联.
结论:
- 了解基于DNA甲基化的血管生成调节对于开发乳腺癌新型治疗策略至关重要.
- 向DNA甲基化可能为控制瘤血管生成和改善患者预后提供新的途径.
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


